Tremeau Pharmaceuticals, Inc. — Form D
Tremeau Pharmaceuticals, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-02-15. The offering totals $5.2M, of which $5.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-02-15
- Form: D
- Accession: 0001144204-18-009165
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.2M
- Amount sold: $5.2M
- Minimum investment: $10K
- Investors: 59
- Date of first sale: 2016-10-17
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-305704
Issuer
- Name: Tremeau Pharmaceuticals, Inc.
- CIK: 0001722110
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: ONE BROADWAY, CAMBRIDGE, MA, 02142
- Phone: 6176748196
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Bradford C Sippy | Director | Concord, MA |
| Mark C Corrigan | Executive Officer | Cambridge, MA |
| Benjamin C Enerson | Executive Officer | Cambridge, MA |
| Bradford C Sippy | Executive Officer | Concord, MA |
More